Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Patient Education
Share your love
AbbVie Introduces Refresh Tears PF and Refresh Relieva PF Xtra
AbbVie has introduced two new preservative-free (PF) lubricant eye drop products─Refresh Tears PF and Refresh Relieva PF Xtra. These new additions aim to enhance the options available for eye care with innovative features tailored for user convenience and eye health.…
Eyenovia Pediatric Myopia Trial Falls Short
Eyenovia has announced that its Phase 3 CHAPERONE study, aimed at treating pediatric progressive myopia, failed to meet its primary endpoint. The trial evaluated the company’s proprietary drug-device combination using low-dose atropine delivered via the Optejet platform. A review by…
Cequa Shows Positive Phase 4 Results for Dry Eye
Sun Pharmaceutical has shared new Phase 4 clinical trial data, showcasing the efficacy of Cequa (cyclosporine ophthalmic solution) 0.09% in treating dry eye disease (DED). The results reveal that Cequa provides sustained improvements in patients whose symptoms were inadequately managed…
Bausch + Lomb Recycles 94M Eye Care Waste Units
Bausch + Lomb has announced a major milestone in its sustainability efforts. Through its exclusive recycling initiatives—ONE by ONE Recycling and Biotrue Eye Care Recycling programs—the company has collected 94,119,275 units of used contact lenses, eye care products, and lens…
MediPrint Announces Positive Results for Glaucoma Lens
MediPrint Ophthalmics has revealed positive findings from its Phase 2b clinical trial for LL-BMT1, a 3D-printed, drug-eluting contact lens designed to treat mild to moderate glaucoma. These results, presented by Ian Ben Gaddie, OD, FAAO, at the American Academy of…
Atsena & Nippon Shinyaku Partner on ATSN-101
Atsena Therapeutics, Inc. and Nippon Shinyaku Co., Ltd. have entered an exclusive licensing agreement to advance and commercialize ATSN-101, an investigational gene therapy for Leber congenital amaurosis type 1 (LCA1), in both the United States and Japan. ATSN-101 is designed…
Oklahoma Doctor Wins $2.3M NIH for Retinopathy Research
Dr. Faizah Bhatti, a neonatologist and researcher from the University of Oklahoma, has been awarded a 5-year, $2.3 million grant from the National Institutes of Health (NIH) to investigate the role of surfactant protein A in the development of retinopathy…
Harrow Gains Medicare Part D Access for Vevye in 2025
Harrow has announced that its dry eye disease treatment, Vevye, will be added to the formularies of key Medicare Part D plan sponsors starting January 1, 2025. Major plan sponsors including Express Scripts, Cigna, Kaiser Permanente, and CVS Caremark, which…
Top 15 International Ophthalmology Congresses in 2024
As the field of ophthalmology continues to advance, a plethora of international congresses offer opportunities for professionals to explore the latest innovations, share insights, and foster collaborations. Here is a comprehensive list of the top 15 international ophthalmology conferences scheduled…
Ocular Rosacea – American Academy of Ophthalmology
Ocular Rosacea American Academy of Ophthalmology Source: Author: | Date: 2024-11-13 08:00:00 Source: Author: | Date: 2024-11-13 08:00:00